These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9029534)

  • 41. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.
    Sandres K; Dubois M; Pasquier C; Payen JL; Alric L; Duffaut M; Vinel JP; Pascal JP; Puel J; Izopet J
    J Virol; 2000 Jan; 74(2):661-8. PubMed ID: 10623727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission.
    Sitia G; Cella D; De Mitri MS; Novati R; Foppa CU; Perackis K; Bianchi C; Lazzarin A; Morsica G
    J Med Virol; 2001 Aug; 64(4):476-81. PubMed ID: 11468732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.
    Lee JH; von Wagner M; Roth WK; Teuber G; Sarrazin C; Zeuzem S
    J Hepatol; 1998 Jul; 29(1):29-35. PubMed ID: 9696489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing.
    Wilson JJ; Polyak SJ; Day TD; Gretch DR
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1763-71. PubMed ID: 9049381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy.
    Nagasaka A; Hige S; Tsunematsu I; Yoshida J; Sasaki Y; Matsushima T; Asaka M
    J Med Virol; 1996 Nov; 50(3):214-20. PubMed ID: 8923285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions.
    Ramachandran S; Xia GL; Ganova-Raeva LM; Nainan OV; Khudyakov Y
    J Virol Methods; 2008 Aug; 151(2):217-224. PubMed ID: 18571738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is single-strand conformation polymorphism analysis of the full 5' untranslated region an adequate approach to study hepatitis C virus quasispecies distribution?
    Vera-Otarola J; Barría MI; León U; Carvallo P; Soza A; López-Lastra M
    J Virol; 2009 Sep; 83(17):9018-21. PubMed ID: 19553315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Host dependent variation of hepatitis C virus: phylogenetic analyses.
    Maekawa S; Enomoto N; Kurosaki M; Marumo F; Sato C
    Arch Virol; 1995; 140(12):2123-33. PubMed ID: 8572936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis.
    Kao JH; Chen PJ; Lai MY; Wang TH; Chen DS
    J Infect Dis; 1995 Jul; 172(1):261-4. PubMed ID: 7797927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus.
    Toyoda H; Fukuda Y; Koyama Y; Takamatsu J; Saito H; Hayakawa T
    J Hepatol; 1997 May; 26(5):975-82. PubMed ID: 9186827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between hepatitis C virus 5' untranslated region quasispecies in serum and liver.
    Jang SJ; Wang LF; Radkowski M; Rakela J; Laskus T
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():711-716. PubMed ID: 10092011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of 5' non-coding region in hepatitis C virus by single-strand conformation polymorphism and low-stringency single specific primer PCR.
    Stamenkovic G; Guduric J; Velickovic Z; Skerl V; Krtolica K; Veljkovic E; Dimitrijevic B
    Clin Chem Lab Med; 2001 Oct; 39(10):948-52. PubMed ID: 11758608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection.
    Navas MC; Fuchs A; Schvoerer E; Bohbot A; Aubertin AM; Stoll-Keller F
    J Med Virol; 2002 Jun; 67(2):152-61. PubMed ID: 11992576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication.
    Laskus T; Radkowski M; Wang LF; Jang SJ; Vargas H; Rakela J
    Virology; 1998 Aug; 248(1):164-71. PubMed ID: 9705266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients.
    Kim CJ; Shin KS; Kim WY; Lim DS; Yoon SK; Park YM; Kim BS; Jang SK; Cho MJ
    J Med Virol; 1995 Aug; 46(4):380-6. PubMed ID: 7595417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients.
    Gretch DR; Polyak SJ; Wilson JJ; Carithers RL; Perkins JD; Corey L
    J Virol; 1996 Nov; 70(11):7622-31. PubMed ID: 8892882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees.
    Nainan OV; Lu L; Gao FX; Meeks E; Robertson BH; Margolis HS
    J Gen Virol; 2006 Jan; 87(Pt 1):83-91. PubMed ID: 16361420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group.
    Hagiwara H; Hayashi N; Kasahara A; Oshita M; Katayama K; Kato M; Masuzawa M; Fusamoto H; Sakurai M; Kamada T
    Scand J Gastroenterol; 1996 Oct; 31(10):1021-6. PubMed ID: 8898424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.